Navigation Links
CryoLife to Distribute FDA-approved Hemostatic Agent Under Private Label
Date:4/17/2008

d in Canada and Australia for use in soft tissue repair. The Company also distributes the CryoLife-O'Brien(R) stentless porcine heart valve, which is CE marked for distribution within the European Community.

About Medafor Inc.

Medafor is a privately held Minneapolis based medical device company that has commercialized a naturally absorbent starch based hemostatic powder engineered to rapidly dehydrate blood and enhance clotting. This powder, which is Medafor's microporous polysaccharide hemostatic agent, has been commercialized for use in both intra-operative surgical procedures as well as numerous topical applications worldwide. This agent has a number of cost and safety features important to both surgeons and patients. The Company received FDA approval for surgical use of this product in September 2006 and has had CE Mark approval since 2003.

Statements made in this press release that look forward in time or that express management's beliefs, expectations or hopes are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include those regarding the ability of the Company to begin distributing the Hemostase MPH product when expected, the ability of the Company to compete in the surgical hemostat market, and expectations regarding the market penetration of Hemostase MPH. These future events may not occur as and when expected, if at all, and, together with the Company's business, are subject to various risks and uncertainties. These risks and uncertainties include that the Company may be unable to effectively leverage its existing sales force to sell a new product, that surgeons may not choose to utilize Hemostase MPH, and that Hemostase MPH may not perform as expected or provide all expected benefits. In addition, the Company's business is subject to the following risks: the Company's strategic directives may not generate anticipated revenue and earnings growth, that the Company i
'/>"/>

SOURCE CryoLife, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. CryoLife Closes on $15 Million Credit Facility with GE Healthcare Financial Services
2. CryoLife Announces Implant of First FDA-Cleared SynerGraft(R) Processed Human Pulmonary Heart Valve
3. CryoLife to Present at Roth Capital Partners 20th Annual Orange County (OC) Growth Stock Conference
4. CryoLife Receives FDA 510(k) Clearance for SynerGraft(R) Processed Human Pulmonary Heart Valves
5. CryoLife Announces Release Date and Teleconference Call Details for the Fourth Quarter and Year End 2007 Financial Results
6. Cryolife Once Again Severely Maims an Innocent Knee Surgery Patient
7. CryoLife Responds to Inaccurate Assertions from Plaintiffs Attorney
8. CryoLife Announces Record Preservation Services and Product Revenues for 2007
9. CryoLife to Present at OneMedPlace Finance Forum
10. CryoLife to Present at 19th Annual Piper Jaffray Health Care Conference in New York
11. CryoLife to Conduct Annual Cardiac Surgery Fellows Allograft Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... NY (PRWEB) March 06, 2015 Transparency Market ... Vegetables and Other Crops - Global Industry Analysis, Size, Share, ... report, the global isoxaflutole market was valued at US$ 116.3 ... Mn by 2020, expanding at a CAGR of 5.1% from ... for isoxaflutole stood at 2,569.5 kilo tons in 2013. , ...
(Date:3/5/2015)... 5, 2015  DuPont (NYSE: DD ) ... Industrials Conference held today in New York ... Trerotola discussed strategy, progress and plans to accelerate ...  Strengthening and growing the company,s leading position in high-value ... strategic priority for DuPont. Discussing the company,s ...
(Date:3/5/2015)... 05, 2015 Plant disease specialists from ... at the Annual Meeting of The American Phytopathological Society. ... released online now at APSnet.org/meet . , The ... meeting, to be held August 1-5, 2015 in Pasadena, ... Field Trips, Workshops, and committee meetings, all carefully balanced ...
(Date:3/5/2015)... and TORONTO , March 5, ... a clinical-stage company developing new therapeutics and molecular diagnostics ... that William G. Rice , Ph.D., Chairman, President ... 27th Annual ROTH Conference on Tuesday, March 10 th ... Carlton, Laguna Niguel, CA. Dr. ...
Breaking Biology Technology:Isoxaflutole Market is Expected to Reach US$ 163.0 Mn by 2020 : Transparency Market Research 2Isoxaflutole Market is Expected to Reach US$ 163.0 Mn by 2020 : Transparency Market Research 3DuPont Leader Highlights Strategy, Progress and Plans to Accelerate Growth in Advanced Materials and Discusses Near-Term Outlook 2DuPont Leader Highlights Strategy, Progress and Plans to Accelerate Growth in Advanced Materials and Discusses Near-Term Outlook 3DuPont Leader Highlights Strategy, Progress and Plans to Accelerate Growth in Advanced Materials and Discusses Near-Term Outlook 4American Phytopathological Society Announces Annual Meeting Daily Schedule 2Aptose Biosciences to Present at the 27th Annual ROTH Conference 2Aptose Biosciences to Present at the 27th Annual ROTH Conference 3
... DUBLIN, Ireland, January 9 Azur Pharma ... the exclusive U.S. marketing rights,for Niravam(R) (alprazolam ... Kemstro(TM) (baclofen,orally disintegrating tablets) and Fluxid(TM) (famotidine ... terms were not,disclosed. , ...
... The IN VIVO Blog , which provides news, insights and ... a Deal of the Year for 2008 -- ... than 2,500 reader votes were cast in this inaugural competition, ... the 13 nominees selected by The IN VIVO Blog,s writers ...
... MATK ) announced today that it will be ... The conference is being held January 14-15, 2009 at ... Point, California. Peter L. Buzy, Chief Financial Officer, and ... 2009 at 1:25 PM PT.A live audio webcast of Martek,s ...
Cached Biology Technology:Azur Pharma Announces the Licensing of Niravam, Parcopa, Kemstro and Fluxid From UCB 2The IN VIVO Blog Selects First Annual 'Deal of the Year' 2
(Date:2/5/2015)... New Market Research Reports Title ... To 2020 has Been Added to GrandViewReseach.com Report Database ... to reach USD 5.10 billion by 2020, according to ... cameras help identify the site of tissue damage in ... demand in medical imaging applications. They have been extensively ...
(Date:2/5/2015)... , Feb. 3, 2015 Despite a ... from industries such as consumer electronics, automotive, storage ... surface mount technology (SMT) screen printers. Innovations in ... control will push the adoption curve up. Meanwhile, ... steady as glue dispensers are indispensable in the ...
(Date:1/22/2015)... 13, 2015  Today, FreeWavz ( www.FreeWavz.com ), the ... campaign on Fundable, https://www.fundable.com/freewavz . FreeWavz will ... capacity to meet customer demand. Logo ... http://photos.prnewswire.com/prnh/20150113/168790 Invented by Dr. ...
Breaking Biology News(10 mins):IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 3End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 2End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 3FreeWavz Launches on Fundable to Drive Speed-to-Market in 2015 2
... The Netherlands, December 15 WCC Services, the,leading ... announced that,version 6 of its flagship product, ELISE, ... may receive hundreds of applicants for,each job opening ... for the job.,Security concerns are also at peak ...
... Society for Microbiology (ASM) has been honored with non-profit ... its public outreach initiatives. The awards were announced ... Society,s MicrobeWorld Video series received the award for best ... series strives to increase public understanding and appreciation of ...
... GeneVision: the uncanny ability to view the activity of ... modified camera. With GeneVision, military commanders could compare ... track genes related to craving as shoppers moved about ... secret advantage over his love-struck dates. Frightening? Perhaps. ...
Cached Biology News:WCC Announces Version 6 of its ELISE Smart Search and Match Platform for Employment and Biometric Matching 2Real-time gene monitoring developed 2
... is formulated for covering tissue sections and cell ... OR alcohol insoluble end products. UltraMount ... Fast Red or AEC that require an aqueous ... as DAB. No heating is required prior to ...
... Rabbit polyclonal to JAK2 (phospho ... tested applications). Antigen: ... JAK2 around the phosphorylation site of ... Entrez Gene ID: ...
Rabbit polyclonal to JNK1 (phospho T183 + Y185) ( Abpromise for all tested applications). entrezGeneID: 5599 SwissProtID: P45983...
... ( Abpromise for all tested applications). ... conjugated to KLH derived from within residues ... amino acid sequence is proprietary)(Peptide available as ... Gene ID: 55693 ...
Biology Products: